𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Acute hepatitis C in Brazil: Results of a national survey

✍ Scribed by Adalgisa de Souza Paiva Ferreira; Renata de Mello Perez; Maria Lucia Gomes Ferraz; Lia Laura Lewis-Ximenez; João Luis Pereira; Paulo Roberto Lerias de Almeida; Angelo Alves de Mattos; on behalf of The Acute Hepatitis C Study Group of The Brazilian Society of Hepatology


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
80 KB
Volume
83
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The incidence of acute hepatitis C has decreased in the world. However, new cases are still reported. The objective of this study was to obtain data of acute hepatitis C in Brazil and to identify risk factors of transmission, diagnostic criteria, clinical presentation, evolution, and treatment. A questionnaire was sent to all members of the Brazilian Society of Hepatology. Sixteen centers participated with a total of 170 cases between 2000 and 2008. Among them, 37 had chronic renal failure on hemodialysis and were evaluated separately. The main diagnostic criterion in non‐uremic patients was ALT (alanine aminotransferase) elevation associated with risk factors. In patients with chronic renal failure, anti‐hepatitis C virus (HCV) seroconversion was the most frequent criterion. Among the 133 non‐uremic patients the main risk factors were hospital procedures, whereas in hemodialysis patients, dialysis was the single risk factor in 95% of the cases. Jaundice was more frequent in non‐uremic patients (82% vs. 13%; P < 0.001) and ALT levels were higher in these individuals (P < 0.001). Spontaneous clearance was more frequent in non‐uremic patients (51% vs. 3%; P < 0.001). Sixty‐five patients were treated: 39 non‐uremic patients and 26 on dialysis. Sustained virological response rates were 60% for non‐uremic and 58% for uremic patients (P = 0.98). There was no association of these rates with the study variables. These findings show that cases of acute hepatitis C are still occurring and have been related predominantly to hospital procedures. Measures to prevent nosocomial transmission should be adopted rigorously and followed to minimize this important source of infection observed in this survey. J. Med. Virol. 83:1738–1743, 2011. © 2011 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Management of hepatitis C: A national su
✍ J E Everhart; M Stolar; J H Hoofnagle 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 1 views

Abbreviations: HCV, hepatitis C virus; ALT, alanine aminotransferase. From the Epidemiology and Clinical Trials Branch, Division of Digestive Diseases by 1.8% to 13.8% of respondents. These missing responses and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, were exclud

Hematology/oncology fellows' training in
✍ Mary K. Buss; David S. Lessen; Amy M. Sullivan; Jamie Von Roenn; Robert M. Arnol 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

## Abstract ## BACKGROUND: Palliative care is recognized as integral to the practice of oncology, yet many oncologists report inadequate training in critical palliative care domains, such as symptom management, psychosocial care, and communication skills. The authors of this report sought to asses

Performance characteristics and results
✍ S Kaur; L Rybicki; B R Bacon; J L Gollan; V K Rustgi; W D Carey 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views

Screening programs to detect diseases such as hyperten-Chronic viral hepatitis frequently goes undetected unsion, hyperlipidemia, breast cancer, and colorectal cancer til cirrhosis develops. Although the effect of interferon have been conducted for years in the United States. [1][2][3][4][5][6] Suco

A national French survey on the use of g
✍ Thierry Thévenot; Jean-François Cadranel; Vincent Di Martino; Alexandre Pariente 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 2 views

We conducted a national retrospective survey on hospital practitioners to evaluate the magnitude of erythropoietin (EPO) or granulocyte colony-stimulating factor (G-CSF) prescriptions in patients treated for chronic hepatitis C. Four hundred seventy-one questionnaires were sent, and 274 practitioner

Duration of peginterferon therapy in acu
✍ Sanaa M. Kamal; Khairy N. Moustafa; Jason Chen; Jutta Fehr; Azza Abdel Moneim; K 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB 👁 1 views

Spontaneous resolution of acute hepatitis C virus infection cannot be predicted, and chronic evolution of the disease occurs in a majority of cases. To assess the efficacy and safety of peginterferon alpha-2b administered for 8, 12, or 24 weeks in patients with acute hepatitis C virus infection a to